Clinical Review 23 September 2026
Distinguishing patients who need medical treatment and observation from those requiring targeted respiratory support or urgent escalation.
Read article → Research 22 September 2026
A French observational study found fewer major cardiovascular events with atenolol over two years—but no statistically significant mortality difference.
Read article → Clinical Review 15 September 2026
Long-term antibiotics can prevent spontaneous bacterial peritonitis in selected patients with cirrhosis, but treatment and withdrawal decisions require careful risk–benefit assessment.
Read article → Guidelines in Practice 10 September 2026
A practical guide to confirming malaria, assessing severity, selecting treatment, and responding safely in special populations.
Read article → Guidelines in Practice 8 September 2026
A practical approach to diagnosis, multimodality imaging, antimicrobial treatment, surgical timing and post-operative care.
Read article → Guidelines in Practice 31 August 2026
A practical pharmacologic approach for adult migraine prevention
Read article → Research 30 August 2026
The randomised trial tested whether metformin provides cardiovascular protection beyond glucose lowering in HFrEF.
Read article → Clinical Review 30 August 2026
Earlier intervention, better phenotyping and lifetime planning are reshaping aortic, mitral and tricuspid valve care.
Read article → Guidelines in Practice 29 August 2026
A pathophysiology-based definition centred on three essential diagnostic pillars.
Read article → Guidelines in Practice 28 August 2026
A mechanism-based framework for distinguishing myocardial infarction from myocardial injury and identifying its cause.
Read article → Clinical Review 28 August 2026
Understanding stages, ejection-fraction phenotypes and changing disease trajectories without forcing false equivalence.
Read article → Guidelines in Practice 28 August 2026
A practical approach to managing chronic kidney disease and cardiovascular disease together.
Read article → Guidelines in Practice 28 August 2026
A practical guide to classification, diagnosis, foundational therapy, decompensated HF, devices, comorbidities, advanced HF and follow-up.
Read article → Clinical Update 27 August 2026
Lisraya becomes the first FDA-approved oral therapy specifically indicated for adults with dermatomyositis.
Read article → Guidelines in Practice 27 August 2026
A practical approach to rehabilitation timing, exercise, mental health and long-term recovery.
Read article → Clinical Review 13 August 2026
A practical summary of current evidence on timing, clinical setting and patient selection.
Read article → Guidelines in Practice 30 July 2026
A practical guide to treating ESBL-E, AmpC-E, CRE, DTR Pseudomonas aeruginosa, CRAB and Stenotrophomonas maltophilia.
Read article → Research July 2026
A US cause-specific modelling analysis estimates how weekly alcohol intake and drinking pattern relate to lifetime mortality, morbidity and injury risk.
Read article → Research 25 May 2026
Phase 1 data suggest that one-time in-vivo PCSK9 editing can produce large and durable LDL-C reductions, although long-term safety and cardiovascular benefit remain uncertain.
Read article → Guidelines in Practice May 2026
From initial severity assessment to bronchodilator treatment, escalation, discharge and prevention of recurrent exacerbations.
Read article → Clinical Review 19 February 2026
From clinical suspicion and D-dimer testing to the new AHA/ACC PE categories, anticoagulation, reperfusion therapy and follow-up.
Read article → Guidelines in Practice 8 December 2025
What clinicians need to know about diagnosing COPD, the revised ABE assessment, initial and follow-up treatment, exacerbation prevention, biologic therapy and acute exacerbation management.
Read article →